Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity

Nitric oxide mechanisms in the pathogenesis of global risk

Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions

A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome

Lipid peroxidation induces cholesterol domain formation in model membranes

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

A rationale for combined therapy with a calcium channel blocker and a statin: evaluation of basic and clinical evidence

A rationale for combination therapy in risk factor management: a mechanistic perspective